We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Merck, Schering Merger Puts Pressure On Regulators

Law360 (March 9, 2009, 12:00 AM EDT) -- Merck & Co.’s plan to merge with Schering-Plough Corp. in a $41.1 billion deal announced Monday is prompting questions over how antitrust regulators will tackle the second proposal in as many months to combine two pharmaceutical industry giants.

The Merck and Schering deal comes just six weeks after Pfizer Inc. revealed its own plans to take over Wyeth Inc. in a deal valued at $68 billion.

Many U.S. drugmakers are facing patent expirations of a number of their blockbuster drugs in the next few years, and...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.